New Jersey Senate Bill S1148

New Jersey 2022-2023 Regular Session

• Introduced: 1/31/22
• Refer: 1/31/22

Caption

Allows pharmacists to prescribe and dispense self-administered hormonal contraceptives under certain circumstances.

Impact

The legislation is expected to improve access to hormonal contraceptives, particularly for individuals who might face barriers in accessing healthcare providers directly. By enabling pharmacists to prescribe these medications, the bill could streamline the process for many women seeking contraception, thereby aligning New Jersey with similar initiatives seen in states like California and Oregon. This could potentially lead to increased public health outcomes regarding reproductive health in the state.

Summary

Bill S1148 addresses the authority of pharmacists in New Jersey by allowing them to prescribe and dispense self-administered hormonal contraceptives. Under this legislation, pharmacists must adhere to procedures set forth by the State Board of Pharmacy, which will develop comprehensive guidelines in consultation with medical boards and professional organizations. This includes the requirement for pharmacists to complete a training program, utilize a self-screening risk assessment tool for patients, and ensure patients receive referrals to primary care providers after receiving prescriptions.

Contention

Critics of the bill may express concerns regarding the adequacy of training for pharmacists to manage and prescribe hormonal contraceptives effectively. There may also be apprehension about whether pharmacists can fully evaluate patients' health histories or potential risks compared to traditional healthcare providers. Additionally, the stipulation that patients must show proof of a clinical visit within the last three years might present difficulties for certain individuals, thereby posing challenges to enhanced access.